JP2022513019A5 - - Google Patents

Info

Publication number
JP2022513019A5
JP2022513019A5 JP2021525806A JP2021525806A JP2022513019A5 JP 2022513019 A5 JP2022513019 A5 JP 2022513019A5 JP 2021525806 A JP2021525806 A JP 2021525806A JP 2021525806 A JP2021525806 A JP 2021525806A JP 2022513019 A5 JP2022513019 A5 JP 2022513019A5
Authority
JP
Japan
Prior art keywords
immunogenic peptide
khr
antigen
cells
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021525806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/080925 external-priority patent/WO2020099352A2/en
Publication of JP2022513019A publication Critical patent/JP2022513019A/ja
Publication of JP2022513019A5 publication Critical patent/JP2022513019A5/ja
Pending legal-status Critical Current

Links

JP2021525806A 2018-11-12 2019-11-12 新規の酸化還元酵素モチーフを有する免疫原性ペプチド Pending JP2022513019A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18205611.9 2018-11-12
EP18205615.0 2018-11-12
EP18205611 2018-11-12
EP18205615 2018-11-12
PCT/EP2019/080925 WO2020099352A2 (en) 2018-11-12 2019-11-12 Immunogenic peptides with new oxidoreductase motifs

Publications (2)

Publication Number Publication Date
JP2022513019A JP2022513019A (ja) 2022-02-07
JP2022513019A5 true JP2022513019A5 (https=) 2022-11-24

Family

ID=68655497

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021525806A Pending JP2022513019A (ja) 2018-11-12 2019-11-12 新規の酸化還元酵素モチーフを有する免疫原性ペプチド
JP2021525809A Pending JP2022513021A (ja) 2018-11-12 2019-11-12 向上した酸化還元酵素モチーフを有する免疫原性ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021525809A Pending JP2022513021A (ja) 2018-11-12 2019-11-12 向上した酸化還元酵素モチーフを有する免疫原性ペプチド

Country Status (18)

Country Link
US (2) US20210401976A1 (https=)
EP (2) EP3880237A2 (https=)
JP (2) JP2022513019A (https=)
KR (1) KR20210093933A (https=)
CN (2) CN113015541A (https=)
AU (2) AU2019377983B2 (https=)
BR (1) BR112021009210A2 (https=)
CA (2) CA3118620A1 (https=)
CO (1) CO2021007060A2 (https=)
CU (1) CU20210041A7 (https=)
IL (1) IL282849A (https=)
MX (1) MX2021005540A (https=)
PE (1) PE20211494A1 (https=)
PH (1) PH12021551101A1 (https=)
SG (1) SG11202104875XA (https=)
TW (1) TW202043255A (https=)
WO (2) WO2020099352A2 (https=)
ZA (1) ZA202102909B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2709176T3 (es) 2006-08-11 2019-04-15 Life Sciences Res Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
GB201418433D0 (en) 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
JP7102430B2 (ja) 2017-03-09 2022-07-19 アンシス・エスア 糖尿病の治療のためのペプチド及び方法
US20210401976A1 (en) * 2018-11-12 2021-12-30 Imcyse Sa Immunogenic peptides with improved oxidoreductase motifs
US20240189404A1 (en) * 2020-05-06 2024-06-13 Imcyse Sa Immunogenic peptides with extended oxidoreductase motifs
EP4146255A1 (en) * 2020-05-06 2023-03-15 Imcyse SA Immunogenic peptides with new oxidoreductase motifs
CN117750971A (zh) 2021-05-26 2024-03-22 易姆赛斯股份公司 治疗或预防自身免疫病的方法
AR126654A1 (es) * 2021-06-29 2023-11-01 Imcyse Sa Péptidos y métodos para el tratamiento de neuromielitis óptica
CN121378402A (zh) * 2025-06-12 2026-01-23 杭州湃肽生化科技有限公司 一种双环肽化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520803A (ja) * 2000-04-21 2004-07-15 コリクサ コーポレイション 尋常性挫瘡の治療および診断のための組成物および方法
WO2003055981A2 (en) * 2001-12-21 2003-07-10 University Of Rochester Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions
WO2004011650A2 (en) * 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses
ES2709176T3 (es) * 2006-08-11 2019-04-15 Life Sciences Res Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
EP2245059B1 (en) 2008-02-14 2017-09-20 Life Sciences Research Partners VZW Cd4+ t-cells with cytolytic properties
ES2584430T3 (es) 2008-02-14 2016-09-27 Life Sciences Research Partners Vzw Estrategias para prevenir y/o tratar las respuestas inmunitarias a los alofactores solubles
EP2106803A1 (en) * 2008-04-04 2009-10-07 Fondazione Centro San Raffaele del Monte Tabor Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
DE11787873T1 (de) 2010-11-25 2013-12-12 Imnate Sarl Immugene Peptide zur Verwendung bei der Vorbeugung und/oder Behandlung von Infektionskrankheiten, Autoimmunerkrankungen, Immunreaktionen auf Allofaktoren, allergischen Erkrankungen, Tumoren, Transplantatabstossungen und Immunreaktionen auf virale Vektoren
GB201201511D0 (en) * 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) * 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
GB201418433D0 (en) * 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
BR112018071466A2 (pt) * 2016-04-19 2019-03-19 Imcyse Sa novos peptídeos de ligação a cd1d imunogênicos
EP3388447A1 (en) * 2017-04-14 2018-10-17 Imnate Sarl Methods to produce peptides, polypeptides or cells for modulating immunity
US20210401976A1 (en) * 2018-11-12 2021-12-30 Imcyse Sa Immunogenic peptides with improved oxidoreductase motifs
US20240189404A1 (en) * 2020-05-06 2024-06-13 Imcyse Sa Immunogenic peptides with extended oxidoreductase motifs

Similar Documents

Publication Publication Date Title
JP2022513019A5 (https=)
JP2022513021A5 (https=)
AU2020200137B2 (en) Yeast-MUC1 immunotherapeutic compositions and uses thereof
EP2928493B1 (en) Fusion proteins for use as immunogenic enhancers for inducing antigen-specific t cell responses
Rodriguez-Del Rio et al. A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection
ES2676630T3 (es) Control inmunogénico de tumores y células tumorales
DK1581174T3 (en) Yeast-based vaccines such as immunotherapy
ES2924027T3 (es) Péptidos inmunogénicos para su uso en la prevención y/o tratamiento de enfermedades infecciosas, enfermedades autoinmunitarias, respuestas inmunitarias a alofactores, enfermedades alérgicas, tumores, rechazo de injerto y respuestas inmunitarias contra vectores virales usados para terapia génica o vacunación génica
ES2536900T3 (es) Antígenos multivariables en complejo con anticuerpo monoclonal humanizado de dirección
RU2017111657A (ru) Новые иммуногенные пептиды
JP2018504419A5 (https=)
PE20240645A1 (es) Peptido inmunogenico derivado de moleculas de antigenos leucocitarios humanos (hla) como biomarcador en la inmunoterapia de diversos tumores
KR102228843B1 (ko) Cd4+ t-세포 반응의 증강을 위한 변형된 에피토프
EA202091754A1 (ru) Пептиды и комбинации пептидов неканонического происхождения для применения в иммунотерапии различных видов рака
EP3715359A1 (en) Cd4 helper t cell epitope fusion peptide and vaccine therewith
Milani et al. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity
MX2023001449A (es) Peptidos y combinaciones de peptidos para su uso en inmunoterapia contra una infeccion por sars-cov-2 (covid-19).
CR20200632A (es) Péptidos restringidos por a*03 par el uso en la inmunoterapia contra el cáncer y métodos relacionados
MX2022012545A (es) Peptidos y combinaciones de peptidos para usar en la inmunoterapia contra una infeccion por sars-cov-2 (covid-19).
CN113906046A (zh) 具有包含经修饰半胱氨酸的氧化还原酶基序的免疫原性肽
Voskens et al. Synthetic peptide-based cancer vaccines: lessons learned and hurdles to overcome
RU2021115718A (ru) Иммуногенные пептиды с улучшенными мотивами оксидоредуктазы
EA202190572A1 (ru) Иммунотерапия раковых заболеваний рестриктированными по a*01 пептидами и комбинациями пептидов и относящиеся к ней способы
US20250009825A1 (en) Lysates of recombinant yeast for inducing cellular immune responses
EA202191411A1 (ru) Иммунотерапия раковых заболеваний рестриктированными по b*08 пептидами и комбинациями пептидов и связанные с ними способы